Literature DB >> 489921

Stimulation of prolactin release by intravenous cimetidine: a dose-response study.

R Caldara, L Bierti, C Barbieri, M Cambielli, M Romussi, C Ferrari.   

Abstract

The PRL response to iv cimetidine was tested in 8 healthy males and 8 females at 4 different dose levels (0.75, 1.5, 3.0 and 6.0 mg/kg bw). Serum PRL levels were significantly increased in comparison with a placebo study by the second cimetidine dose in both sexes. The PRL response was significantly higher in females than in males at all but the lowest dose tested. A significant correlation between the cimetidine dose and the PRL response was observed. There was no significant modifications in serum GH, LH, FSH, IRI and glucose. Present findings demonstrate that the stimulation of PRL release by iv cimetidine is quite specific and dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 489921     DOI: 10.1007/BF03349280

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Prolactin response to thyrotropin releasing hormone in normal subjects.

Authors:  L S Jacobs; P J Snyder; R D Utiger; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

2.  Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors:  G L Noel; H K Suh; J G Stone; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

3.  Galactorrhoea with cimetidine.

Authors:  M C Bateson; M C Browning; A Maconnachie
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

4.  Cimetidine and serum prolactin.

Authors:  S K Majumdar; A D Thomson; G K Shaw
Journal:  Br Med J       Date:  1978-02-18

5.  Safety of cimetidine.

Authors:  D M Kruss; A Littman
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

6.  Effect of cimetidine on glucose handling.

Authors:  D B Jefferys; J A Vale
Journal:  Lancet       Date:  1978-02-18       Impact factor: 79.321

7.  Plasma-prolactin and cimetidine.

Authors:  M Petrillo; A Prada; G B Porro; M Bevilacqua; V Raggi; G Norbiato
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

8.  Plasma-prolactin and cimetidine.

Authors:  J C Daubresse; J C Meunier; G Logny
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

9.  Serum-prolactin in patients receiving chronic oral cimetidine.

Authors:  A M Spiegel; R Lopatin; S Peikin; D McCarthy
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

10.  Prolactin responses to cimetidine.

Authors:  W L Burland; R I Gleadle; R M Lee; D Rowley-Jones; G V Groom
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more
  3 in total

Review 1.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 2.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

3.  Endocrine effects of acute and chronic cimetidine administration.

Authors:  H E Carlson; A F Ippoliti; R S Swerdloff
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.